M&A Deal Summary |
|
---|---|
Date | 2024-01-08 |
Target | Boston Orthotics & Prosthetics |
Sector | Medical Products |
Buyer(s) | OrthoPediatrics |
Deal Type | Add-on Acquisition |
Deal Value | 22M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2007 |
Sector | Medical Products |
OrthoPediatrics is the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. Children’s bones have anatomical differences such as growth plates that must be protected and curvatures that are greater than in adults. In the past, surgeons have had to modify implants that were primarily designed for adults in an effort to make them work in children.
DEAL STATS | # |
---|---|
Overall | 4 of 4 |
Sector (Medical Products) | 4 of 4 |
Type (Add-on Acquisition) | 3 of 3 |
State (Massachusetts) | 1 of 1 |
Country (United States) | 2 of 2 |
Year (2024) | 1 of 1 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-06-14 |
Pega Medical
Laval, Quebec, Canada Pega Medical is a bioengineering services company focused on key innovations within the trauma and deformity patient population, including developing the Fassier-Duval Telescopic IM System, an innovative implant designed to treat bony deformities in children with osteogenesis imperfecta without disrupting their normal growth. Pega Medical was founded in 1994 and is based in Laval, Quebec. |
Buy | - |